Pfizer, Inc. (PFE) Tops Q2 EPS by 1c; Affirms Outlook
Pfizer, Inc. (NYSE: PFE) reported Q2 EPS of $0.60, $0.01 better than the analyst estimate of $0.59. Revenue for the quarter came in at $16.98 billion versus the consensus estimate of $16.98 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Eli Lilly & Co. (LLY) Tops Q4 EPS by 1c; Trims FY15 Revs Outlook
- Computer Programs & Systems (CPSI) Misses Q4 EPS Views; Issues Light FY15 Guidance
- TimkenSteel (TMST) Misses Q4 EPS by 3c, Offers FY Outlook
Create E-mail Alert Related CategoriesEarnings, Guidance, Hot Earnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!